Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Mar 30, 2024. Filed May 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 30, 2024 · Filed May 7, 2024

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except par value)

As ofMarch 30,2024As ofDecember 30, 2023
ASSETS
Current assets
Cash and cash equivalents$328,336$330,420
Inventories60,87061,454
Prepaid expenses and other current assets31,86425,872
Total current assets421,070417,746
Property and equipment, net98,18699,814
Goodwill16,90217,102
Intangible assets, net29,10529,919
Deferred tax assets11,34713,284
Other assets52,66554,892
$629,275$632,757
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable$8,266$10,070
Line of credit - short term1,320786
Other current liabilities103,045107,989
Total current liabilities112,631118,845
Deferred tax liabilities5,1134,552
Other long-term liabilities11,54312,158
Stockholders' equity
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,047 as of March 30, 2024 and 19,130 as of December 30, 20231919
Additional paid-in capital65,11165,661
Retained earnings453,451445,217
Accumulated other comprehensive income (loss)(18,593)(13,695)
Total stockholders' equity499,988497,202
$629,275$632,757
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.